News Menu

Gut health à la CAR T

Microscopic view of tissue with blue, orange, and black highlighted cells and intricate structures.
Epithelial cells in samples of aged human intestines, shown here, tested positive for uPAR, a surface marker of senescence. They also exhibited a lack or absence of the tumor suppressor p21.

Ever notice that as you get older, some foods no longer sit with you the same? This could be due to a breakdown of the intestinal epithelium, a single layer of cells that forms the organ’s lining. The intestine plays a crucial role in many health functions, including digestion. Under normal conditions, the entire intestinal epithelium typically regenerates every three to five days. However, with damage from old age or cancer radiation, regeneration can stop or slow. That can lead to inflammation and diseases like leaky gut syndrome.

Now, Cold Spring Harbor Laboratory (CSHL) biologists have devised a new way to stimulate cell growth and repair in the intestine. The key to their success is CAR T-cell therapy, a new form of immunotherapy. Their approach could help lay the groundwork for clinical trials aimed at improving gut health in patients with certain age-related conditions.

The development builds on a recent breakthrough from CSHL Assistant Professor Corina Amor Vegas, whose lab specializes in cellular senescence. As we age, our body accumulates cells that stop replicating but don’t die. Senescent cells have been linked to a range of age-related diseases, from diabetes to dementia. Amor Vegas’ lab previously engineered special immune cells called anti-uPAR CAR T cells to eliminate senescent cells in mice, thereby greatly improving the animals’ metabolism.

Microscope slides show stained tissue sections, with varying shades of blue, brown, and pink in three rows.
Treating the intestinal linings with uPAR-targeting CAR T cells improved gut health in both young mice (left) and older animals (right). Treated intestines (shown in the second and fourth columns) exhibited reductions in uPAR cells (top row), as well as reductions in damaged senescent cells (middle row) and increases in healthy stem cells (bottom row).

The question was whether targeting senescent cells in this way might help rejuvenate the intestine. To test the idea, Amor Vegas teamed with CSHL Assistant Professor Semir Beyaz and grad student Onur Eskiocak. The team administered CAR T cells to the intestines of both old and younger mice. “In both cases, we see really significant improvements,” Amor Vegas says. “They’re able to absorb nutrients better. They have much less inflammation. When irritated or injured, their epithelial lining is able to regenerate and heal much faster.”

Leaky gut syndrome is especially common in cancer patients undergoing pelvic or abdominal radiation therapy. The team simulated this kind of therapy by irradiating the mice’s epithelial cells. They found that mice treated with CAR T cells recovered from radiation much better than those that didn’t receive CAR T cells. Importantly, just one administration of CAR T-cell therapy improved the mice’s gut health for at least a year.

The team also found strong evidence that anti-uPAR CAR T cells promote regeneration in human intestinal and colorectal cells, Eskiocak notes. Exactly how this works remains to be determined. Nevertheless, the results are extremely encouraging. “This is one good step toward a long journey in understanding how we can better heal the elderly,” Beyaz said.

Written by: Margaret Osborne, Science Writer | publicaffairs@cshl.edu | 516-367-8455


Funding

National Cancer Institute, Fundación Rafael del Pino Scholarship Program, National Institutes of Health, The Mark Foundation for Cancer Research, Memorial Sloan Kettering Cancer Center, The Oliver S. and Jennie R. Donaldson Charitable Trust, The G. Harold & Leila Y. Mathers Foundation, Starr Cancer Consortium, Chan Zuckerberg Initiative, Silicon Valley Community Foundation, CSHL-Northwell Health Affiliation, Norn Group, National Institute of Aging

Citation

Eskiocak, O., et al., “Anti-uPAR CAR T cells reverse and prevent aging-associated defects in intestinal regeneration and fitness”, Nature Aging, November 25, 2025. DOI: 10.1038/s43587-025-01022-w

Core Facilites

Animal Facility “The Animal Shared Resource houses and cares for the animals essential for scientific research. Our staff perform all aspects of animal husbandry, ensure humane care, and assist researchers with highly technical procedures and protocol design and development.” — Animal Facility Director and Attending Veterinarian Rachel Rubino, DVM

 “The Bioinformatics Core Facility provides researchers with essential services and technical support for Next Gen Sequencing (NGS) analysis. We work closely with researchers from the earliest planning stages of data-intensive experiments to developing customized software tools for analyzing data.” — Director Rad Utama, Ph.D.

“The Flow Cytometry Shared Resource offers researchers equipment, training, and assistance with cellular analysis for a variety of applications as well as cell sorting. Our staff oversees equipment maintenance and quality control, trains new users on instrument operation, and assists with assay development and data analysis. We also provide tissue culture facilities for sample preparation and cell maintenance during ongoing flow cytometry experiments.” — Director Pamela Moody

image of the microscopy core facility icon “The Microscopy Core Facility provides training, consultation, experimental design and technical assistance to investigators at CSHL in widefield, spinning disk laser scanning or point laser scanning confocal fluorescence microscopy, and super-resolution microscopy. In addition, the Microscopy Shared Resource provides customized state-of-the-art optical imaging and quantitative image analysis applications to support a wide range of scientific endeavors.” — Director Erika Wee, Ph.D.

image of organoid icon “The Organoid Shared Resource provides Cancer Center members with access to the reagents, equipment, and expertise needed to culture and perform experiments with three-dimensional organoid models. We offer centralized access to protocols for generating and working with Patient Derived Organoid (PDO) cultures, standardized culture reagents, and Droplet Digital PCR (ddPCR) Technology, as well as training and equipment for performing high-throughput chemical screens on either two-dimensional cell lines or organoid cultures.” — Facility Manager Hardik Patel

image of single-cell biology icon “The Single Cell Genomics Core Facility brings cutting-edge single-cell technologies to collaborators both inside and outside of the Laboratory. We currently specialize in single-cell transcriptomics and offer assistance in a variety of gene expression workflows, including the latest in spatial gene expression profiling technologies.” — Director Jon Preall, Ph.D.

Animal Tissue Imaging “The Tissue Imaging Shared Resource provides a spectrum of on-demand and researcher-tailored histopathological services, including tissue sampling, processing, embedding, and sectioning, as well as H&E, special, and immunohistochemistry staining. We not only support laser-capture microdissection and whole-slide scanning, but also offer histopathology consultation and instrument training.” — Manager Kristin Milicich

Stay informed

Sign up for our newsletter to get the latest discoveries, upcoming events, videos, podcasts, and a news roundup delivered straight to your inbox every month.

  Newsletter Signup

Tags